Negotiating antiretroviral drug prices: The experience of the Andean countries

Health Policy and Planning

Volumn 22, Issue 2, 2007, Pages 63-72

  Seoane Vazquez, Enrique ^a,b   Rodriguez Monguio, Rosa ^a,b  

^a Dept of Epidemiology Biostatistics   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

Andean countries; Antiretroviral drugs; Drug access; Drug prices; HIV AIDS; Price negotiation

Indexed keywords

ABACAVIR; ANTIRETROVIRUS AGENT; DIDANOSINE; EFAVIRENZ; INDINAVIR; LAMIVUDINE; LOPINAVIR; NELFINAVIR; NEVIRAPINE; RITONAVIR; SAQUINAVIR; STAVUDINE; ZIDOVUDINE;

ARTICLE; AUTHORITY; BIOEQUIVALENCE; DRUG COST; EVALUATION; HEALTH CARE; HEALTH CARE COST; HEALTH PROGRAM; INFORMATION PROCESSING; INTERPERSONAL COMMUNICATION; INTERVIEW; PUBLIC HEALTH; PURCHASING; QUALITY CONTROL; QUESTIONNAIRE;

ANTI-RETROVIRAL AGENTS; DATA COLLECTION; DEVELOPING COUNTRIES; DRUG COSTS; HUMANS; INTERNATIONAL COOPERATION; NEGOTIATING; SOUTH AMERICA;

EID: 33847664123     PISSN: 02681080     EISSN: 14602237     Source Type: Journal    
DOI: 10.1093/heapol/czl039     Document Type: Article

References (24)

1. Attaran A, Sachs J. 2001. Defining and refining international donor support for combating the AIDS pandemic. The Lancet 357: 57-61.
2. Attawell K, Mundy J. 2003. Provision of antiretroviral therapy in resource-limited settings: a review of experience up to August 2003. London: DFID Health Systems Resource Centre. Online at: [http://www.who.int/3by5/ publications/documents/en/ARTpaper_DFID_WHO.pdf].
3. Berkman A. 2001. Confronting global AIDS: prevention and treatment. American Journal of Public Health 91: 1348-9.
4. Brugha R. 2003. Antiretroviral treatment in developing countries: the peril of neglecting private providers. British Medical Journal 326: 1382-4.
5. Chequer P, Cuchi P, Mazin R, Garcia Calleja JM. 2002. Access to antiretroviral treatment in Latin American countries and the Caribbean. AIDS 16(Suppl. 3): S50-7.
6. Creese A, Floyd K, Alban A, Guinness L. 2002. Cost-effectiveness of HIV/AIDS interventions in Africa: a systematic review of the evidence. The Lancet 359: 1635-43.
7. Galvao J. 2002. Access to antiretroviral drugs in Brazil. The Lancet 360: 1862-5.
8. Homedes N, Ugalde A. 2006. Improving access to pharmaceuticals in Brazil and Argentina. Health Policy and Planning 21: 123-31.
9. Kates J, Sorian R, Crowley JS et al. 2002. Critical policy challenges in the third decade of the HIV/AIDS epidemic. American Journal of Public Health 92: 1060-3.
10. Kober K, Van Damme W. 2004. Scaling up access to antiretroviral treatment in southern Africa: who will do the job? The Lancet 364: 103-7.
11. Loewenson R, McCoy D. 2004. Access to antiretroviral treatment in Africa. British Medical Journal 328: 241-2.
12. McGough LJ, Reynolds SJ, Quinn TC et al. 2005. Which patients first? Setting priorities for antiretroviral therapy where resources are limited. American Journal of Public Health 95: 1173-80.
13. MSF. 2005. Untangling the web of price reductions: a pricing guide for the purchase of ARV for developing countries. Geneva: Médecins Sans Frontières. Online at: [http://www.accessmed-msf.org/documents/ untanglingtheweb%208.pdf].
14. OASCHU. 2003. Diez países latinoamericanos y un propósito común por las personas que viven con VIH/SIDA. Lima: Organismo Andino de Salud Convenio Hipolito Unanue.
15. Opuni M, Bertozzi S, Bollinger L et al. 2002. Resource requirements to fight HIV/AIDS in Latin America and the Caribbean. AIDS 16(Suppl. 3): S58-65.
16. UNAIDS. 2004. 2004 Report on the global AIDS epidemic: 4th global report. Geneva: Joint United Nations Programme on HIV/AIDS (UNAIDS). Online at: [http://www.unaids.org/bangkok2004/GAR2004_pdf/UNAIDSGlobalReport2004_en. pdf].
17. UNAIDS. 2006. Overview of the Global AIDS Epidemic: Report on the global AIDS epidemic. Online at: [http://www.unaids.org/en/HIV_data/ 2006GlobalReport/default.asp].
18. UNICEF-UNAIDS-WHO-MSF. 2005. Sources and prices of selected medicines and diagnostics for people living with HIV/AIDS. Geneva: Joint UNICEF-UNAIDS-WHO-MSF Project. Online at: [http://www.accessmed-msf.org/ documents/sources.pdf].
19. Vasan A, Hoos D, Mukherjee JS et al. 2006. The pricing and procurement of antiretroviral drugs: an observational study of data from the Global Fund. Bulletin of the World Health Organization 84: 393-8.
20. WHO. 2004a. "3 by 5" Progress Report. Geneva: World Health Organization. Online at: [http://www.who.int/entity/3by5/pr_en.pdf].
21. WHO. 2004b. The World Medicines Situation, 2004. Geneva: World Health Organization. Online at: [http://whqlibdoc.who.int/hq/2004/ WHO_EDM_PAR_2004.5.pdf].
22. WHO. 2006. The World Health Report 2006: Working together for health. Geneva: World Health Organization. Online at: [http://www.who.int/ whr/2006/annex/en].
23. WHO HIV/AIDS. 2004. Plan January 2004 - December 2005. Investing in a Comprehensive Health Sector Response to HIV/AIDS. Scaling up Treatment and Accelerating Prevention. Geneva: World Health Organization. Online at: [http://www.who.int/3by5/en/HIV_AIDSplan.pdf].
24. Zarocostas J. 2004. WHO puts HIV/AIDS pandemic at top of its agenda. The Lancet 363: 1615.